You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Welcome | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 295 No. 23, June 21, 2006

JAMA
	•	Online Features

This Article
•	Abstract
•	Full text
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Contact me when this article is cited

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial
JAMA Vogel et al. 10.1001/jama.295.23.joc60074.

Author in the Room

Author in the Room is an initiative from the Institute for Healthcare Improvement and JAMA to help facilitate the transition of science into practice. This Author in the Room conference took place on July 19, 2006.

Author in the Room Audio - June 21, 2006

Read the editorial by Drs DeAngelis and Berwick.

To register for future conferences, go to the IHI Web Site.

| | |